United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 1,627,800 | 1,725,300 | 1,598,800 | 1,465,800 | 1,288,500 |
| Cost of Goods | 198,700 | 105,700 | 72,700 | 69,000 | 125,900 |
| Gross Profit | 1,429,100 | 1,619,600 | 1,526,100 | 1,396,800 | 1,162,600 |
| Operating Expenses | 624,400 | 805,400 | 465,100 | 697,800 | 624,700 |
| Operating Income | 805,400 | 814,900 | 1,061,700 | 699,000 | 538,800 |
| Interest Expense | 13,900 | 9,000 | 3,900 | 4,700 | 17,600 |
| Other Income | -32,600 | -36,400 | 2,400 | 350,100 | 4,000 |
| Pre-tax Income | 758,900 | 769,500 | 1,060,200 | 1,044,400 | 525,200 |
| Income Tax | 169,700 | 351,600 | 346,500 | 392,800 | 185,100 |
| Net Income Continuous | 589,200 | 417,900 | 713,700 | 651,600 | 340,100 |
| Net Income | $589,200 | $417,900 | $713,700 | $651,600 | $340,100 |
| EPS Basic Total Ops | 13.54 | 9.50 | 16.29 | 14.17 | 7.06 |
| EPS Basic Continuous Ops | 13.54 | 9.50 | 16.29 | 14.17 | 7.06 |
| EPS Diluted Total Ops | 13.39 | 9.31 | 15.25 | 12.72 | 6.28 |
| EPS Diluted Continuous Ops | 13.39 | 9.31 | 15.25 | 12.73 | 6.27 |
| EPS Diluted Before Non-Recurring Items | 13.39 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $841,300 | $845,900 | $1,093,300 | $731,900 | $571,000 |